Flow-activated transcription factor Krüppel-like factor 2 (KLF2) signaling is compromised in pulmonary arterial hypertension (PAH). We aimed to identify KLF2-induced endotheliumprotective exosomal microRNAs of potential therapeutic significance. This study highlights potential therapeutic role of KLF2-induced exosomal microRNAs in PAH.
INTRODUCTION
Pulmonary arterial hypertension (PAH) is a severe lung disorder characterised by progressive vascular remodelling and increased vasoconstriction. Endothelial damage followed by proliferation of vascular endothelial and smooth muscle cells underlie the disease pathology (Ranchoux, Harvey et al., 2018) and hypoxia and inflammation are known contributory factors (Rabinovitch, Guignabert et al., 2014) . Formation of angio-obliterative vascular lesions, driven by vascular endothelial growth factor (VEGF), is a hallmark of severe PAH (Voelkel & Gomez-Arroyo, 2014) .
Recently, a missense mutation in the transcription factor Krüppel-like factor 2 (KLF2) gene was identified in a family with autosomal heritable pulmonary arterial hypertension (HPAH), suggesting that KLF2 signalling may be compromised in the disease (Eichstaedt, Song et al., 2017) .
KLF2 is activated by shear stress and plays a key role in the regulation of lung function and development (Anderson, Kern et al., 1995) . KLF2-null mice exhibit abnormal blood vessel formation, resulting in embryonic haemorrhage and death. Within the blood vessel wall KLF2 is exclusively expressed in endothelial cells and promotes vascular homeostasis, counteracting inflammation, vascular leakage, thrombosis and VEGF-induced angiogenesis (Bhattacharya, Senbanerjee et al., 2005 , SenBanerjee, Lin et al., 2004 , Shi, Zhou et al., 2018 .
KLF2 also inhibits endothelial cell apoptosis, while promoting metabolic quiescence and reducing metabolic dependence on glucose (Doddaballapur, Michalik et al., 2015) . The identification of missense mutation in KLF2 gene is significant, as accumulating evidence implicates reduced KLF2 signalling in PAH pathogenesis. Inhibition of KLF2 expression correlates with increased PH severity in apelin knockout mice exposed to hypoxia (Chandra, Razavi et al., 2011) . KLF2 overexpression improves pulmonary haemodynamics in hypoxic rats (Dungey, Deng et al., 2011) , but can compromise liver function (Chen, Lu et al., 2014 , Manavski, Abel et al., 2017 , so other therapeutic approaches need to be identified. microRNAs (miRNAs) are small (~22 nucleotide long) non-coding RNAs that negatively regulate gene expression at the posttranscriptional level (Small & Olson, 2011) . Recent studies have shown that miRNAs released by the cells in exosomes, small membrane vesicles of 40-100 nm in diameter, can be taken up and modulate recipient cell responses in the immediate neighbourhood as well as in distant organs and tissues (Deng, Blanco et al., 2015 , Zhang, Li et al., 2015 .
Dysregulation of several miRNAs has been demonstrated in human and animal PAH but the choice of which miRNAs to target, constitutes a conceptual challenge (Negi & Chan, 2017) .
For example, the levels of KLF2-dependent miR-150 in plasma exosomes from PAH patients are reduced and correlate with survival (Rhodes, Wharton et al., 2013) . A pioneering work by Hergenreider E et al. demonstrated that transfer of exosomal miRNAs from KLF2-overexpressing endothelial cells to underlying vascular SMCs reduces SMC dedifferentiation, thus representing a promising strategy to combat atherosclerosis (Hergenreider, Heydt et al., 2012) . Exosomes have gained special interest as carriers of miRNAs because of their transportability and the ability to convey information within the circulatory system .
Our approach was to determine whether exosomal miRNAs from KLF2-overexpressing endothelial cells have vasculoprotective effects in PAH. We demonstrate dysregulation of KLF2-induced miRNA signalling in endothelial cells and lung tissues from idiopathic PAH (IPAH) patients and heritable PAH patients with KLF2 mutation and present evidence of homeostatic and anti-remodelling effects of KLF2-induced miR-181a-5p and miR-324-5p in vitro and in vivo.
RESULTS

Endothelial exosomes mimic homeostatic effects of KLF2
In order to study the effects of KLF2-induced exosomes, KLF2 was overexpressed in human pulmonary artery endothelial cells (HPAECs) via adenoviral gene transfer. Recombinant KLF2 showed nuclear localisation ( Figure 1A ) and the level of KLF2 overexpression (~3-fold increase) corresponded to expression level induced by physiological shear stress (10 dynes/cm 2 ) in medium-size pulmonary arteries (Tang, Pickard et al., 2012) .
Exosomes were isolated from conditioned media collected from control (AdGFP) and AdKLF2-GFP-overexpressing (AdKLF2) HPAECs and the purity of the obtained fraction was confirmed by Nanosight LM10 particle tracking and exosomal protein marker analysis KLF2 exosomes also inhibited VEGF-induced proliferation ( Figure 1E and Figure S2 in the Online Data Supplement) and serum-induced cell proliferation (data not shown) in HPAECs, mimicking to a large extent the effects induced by KLF2 overexpression ( Figure 1F -H). Figure 2 .
Identification of endothelium
The list of KLF2 miRNAs was then compared with published lists of miRNAs differentially expressed in human PAH and chronic hypoxia and MCT rat models of PAH (Caruso, MacLean et al., 2010 , Rhodes et al., 2013 . Eight miRNAs increased by KLF2 but reduced in human or animal PAH, were selected for further studies. The selected miRNAs comprised of let-7a-5p, miR-10a-5p, miR-125b-5p, miR-181a-5p, miR-191-5p, miR-30a-3p, miR-30c-5p, and miR-324-5p (Table S2 in the Online Data Supplement).
To verify whether miRNAs can pass from cell to cell under flow conditions, HPAECs were cultured in Ibidi flow chambers connected in tandem ( Figure S3 in the Online Data Supplement). The cells grown in the first chamber were transfected with fluorescent Cy3-miR and then the unbound probe was washed away before the onset of flow at 4 dynes/cm 2 .
The results show a directional transfer of fluorescent miRNA between endothelial cells under flow ( Figure S3 in the Online Data Supplement).
Endothelium-protective effects of miR-181 and miR-324
To verify the role of the 8 selected exosomal miRNAs, HPAECs were transfected with miRNA mimics prior to starvation, hypoxic exposure or stimulation of cells with TNF-α.
Transfection efficiency, evaluated with Cy3-labelled miRNA, was ~ 80 ± 5%.
Only miR-181a-5p and miR-324-5p (referred in the manuscript as miR-181 and miR-324),
were protective in all study conditions ( Figure To see if miR-181 and miR-324 play a role in endothelial-to-smooth muscle cell communication, human pulmonary artery smooth muscle cells (HPASMCs) were co-cultured with KLF2-overexpressing HPAECs in Transwell dishes. The two cell types were separated by a porous membrane ( Figure 4A ), which allows exchange of exosomal particles (Hergenreider et al., 2012) . HPASMCs co-cultured with KLF2-overexpressing HPAECs showed elevated intracellular levels of miR-181 and miR-324 ( Figure 4B , C) and reduced PDGF-and hypoxia-induced proliferation, compared with control cells ( Figure 4D , E). The decrease in HPASMC proliferation was prevented by miR-181 and miR-324 inhibitors ( Figure 4E ).
RNA profiling in miR-181 and miR-324-overexpressing HPAECs.
HPAECs transfected with miR-181, miR-324 or non-targeting, control miRNA, were subjected to RNA profiling to identify targets of potential therapeutic significance.
The list of transcripts that were downregulated by miR-181 and miR-324 with fold-change >1.5 and adjusted p value <0.01 (977 for miR-181 and 930 for miR-324) and up-regulated (240 for miR-181 and 251 for miR-324) was compared with the list of predicted in silico target genes.
36 target genes of miR-181 and 37 target genes of miR-324 were then selected for pathway enrichment analysis ( Figure 5A , Figure S7 and Tables S3, S4 ; VEGF (p-adj=1.32 x10 -2 ) ( Figure 5B and Table S5 in the Online Data Supplement). Key targets of miR-181a-5p associated with inflammation, cell proliferation and vascular remodelling included α-SMA, TNF-α, IL-1, Notch4, MMP10, while targets of miR-324-5p included MAPK, NFATC2, ETS-1 (Table S5 in the Online Data Supplement). No significant KEGG pathway associations were found for targets up-regulated by miR-181 and miR-324.
Dysregulation of KLF2, miR-181 and miR-324 and their target genes in human PAH
Blood-derived endothelial colony-forming cells (ECFCs) are often used as surrogates for pulmonary endothelial cells in PAH. We examined the levels of KLF2, miR-181 and miR- The RNAscope fluorescent in situ hybridization, which allows specific identification and quantification of single transcripts (Wang, Flanagan et al., 2012) , showed a marked reduction in the endothelial KLF2 mRNA and increased expression of Notch4 and ETS-1 mRNA in the remodelled vasculature of IPAH patients, compared with healthy lungs (n=6/group) ( Figure 7 A-E).
Lung tissues from HPAH patients with disabling c-terminal KLF2 mutation (n=3) also showed a marked upregulation of Notch4 and ETS-1 in the remodelled vasculature, identified by endothelial vWF and a prominent α-SMA staining in the small, normally nonmuscularised arterioles ( Figure 7 F-I).
miR-181 and miR-324 supplementation attenuates Sugen/hypoxia PH in mice
As a proof-of-concept, the Sugen/hypoxia mouse model of PAH was employed to study changes in the expression of KLF2 and miR-181 and miR-324 target genes in the remodelled lung, and to evaluate therapeutic potential of miR-181 and miR-324. In Sugen/hypoxia preclinical models of PAH, inhibition of VEGF receptor by Sugen (SU5416) induces an exaggerated vascular repair, driven largely by VEGF signaling, which further increases disease severity (Voelkel & Gomez-Arroyo, 2014) .
Pilot experiments confirmed the enhanced effect of combined treatment ( Figure Figure 8I ).
DISCUSSION
Exosome-mediated transfer of specific miRNAs between different cell types modulates vascular function (Aliotta, Pereira et al., 2016 , Deng et al., 2015 , Hergenreider et al., 2012 .
We sought to determine whether exosomal miRNAs from KLF2-overexpressing endothelial cells have a vasculo-protective effect in PAH. We show that delivery of selected KLF2-induced exosomal miRNAs improves pulmonary endothelial cell survival, reduces inflammatory responses and restricts vascular cell proliferation in vitro and in vivo.
To identify mediators of these effects, we conducted an unbiased screen of exosomal miRNAs and selected 8 miRNAs of interest, which were upregulated by KLF2 but reduced in PAH, with the view of potential therapeutic intervention. Of these, only miR-181 and miR-324 were protective in all experimental conditions and their effects were enhanced by the combined treatment. Functional convergence of multiple miRNAs on disease-relevant pathways has been demonstrated in the prevention of cardiac dysfunction and cancer (Chen, Duan et al., 2013 , Huang, Tian et al., 2016 , Negi & Chan, 2017 , Su, Chang et al., 2013 . The miR-181 family suppress NF-κB signalling and regulate endothelial cell activation, proliferation and immune cell homeostasis (Sun, Sit et al., 2014) . Specifically, miR-181a-5p
downregulates TNF-α, the key mediator of inflammatory responses in PAH . In vascular SMCs miR-181a inhibits angiotensin II signalling, the adhesion of vascular SMCs to collagen and the expression of α-smooth muscle cell actin, suggesting that miR-181 may negatively modulate proliferative and migratory behaviour of HPASMCs in PAH (Remus, Lyle et al., 2013) . We observed co-temporary, opposing changes in the expression of miR-181 and its target, Notch4, in the remodelled lungs of human PAH patients and Sugen/hypoxia mice. Notch4 predominantly localises to the vascular endothelium and regulates cell apoptosis, proliferation and VEGF-driven angiogenesis (Funahashi, Shawber et al., 2011 , Hainaud, Contreres et al., 2006 . Its expression is increased by VEGF and FGF (Marcelo, Goldie et al., 2013) , both abundant in the remodelled PAH lung (Jonigk, Golpon et al., 2011 , Voelkel & Gomez-Arroyo, 2014 . Expression of Notch 1-4 is elevated in the remodelled lungs of hypoxic rats, with Notch4 mRNA showing the highest (5-fold) increase (Qiao, Xie et al., 2012) . Consistent with this, we found that the levels of Notch4 mRNA were significantly elevated in blood-derived IPAH ECFCs, in the plexiform lesions in IPAH lungs (Jonigk et al., 2011) and in the remodelled lung tissues from HPAH patients with a KLF2 mutation.
miR-324 controls proliferation, angiogenesis and oxygen metabolism in cells. We noted that miR-324 expression was significantly reduced, while expression of its key target, transcription factor ETS-1, was increased in ECFCs from IPAH patients, lung tissues from IPAH and HPAH patients and lungs from Sugen/hypoxia mice. ETS-1 activation is associated with expansive cell proliferation; high expression levels of ETS-1 facilitate the invasive behaviour of tumour cells and are predictive of the poor prognosis in multiple types of carcinoma (Dittmer, 2015) . ETS-1 also regulates VEGFinduces transcriptional responses (Chen, Fu et al., 2017) , increases endothelial angiogenesis, extracellular matrix remodelling and the expression of glycolytic enzymes and associated feeder pathways (Verschoor, Wilson et al., 2010) , known to augment vascular remodelling in PAH (Cao, Xie et al., 2015 , Ryan & Archer, 2015 .
ECFCs from IPAH patients display many of cellular abnormalities associated with the disease, including hyperproliferation, mitochondrial dysfunction and impaired ability to form vascular networks, reflective of the exaggerated repair processes in the remodelled lung (Caruso, Dunmore et al., 2017 , Duong, Erzurum et al., 2011 , Ormiston, Toshner et al., 2015 , Smits, Tasev et al., 2018 , Wojciak-Stothard, Abdul-Salam et al., 2014a . We observed that proliferative and angiogenic responses of IPAH ECFCs were reduced by overexpression of miR-181 and miR-324 and by silencing of Notch4 and ETS-1.
Homeostatic effects of KLF2 exosomes are likely to result from the cumulative reduction in expression of multiple targets of miR-181 and miR-324. Considering that miRNAs regulate the expression levels of multiple genes simultaneously and often cooperatively (Small & Olson, 2011) , delineating individual contributions of miR-181 and miR-324 gene targets is beyond the scope of this investigation.
KLF2 encourages selective sorting of miRNAs into exosomes (Jae, McEwan et al., 2015) and our data indicate that miR-181a-5p and miR-324-5p are actively exported by the cells.
Although the mechanism of miRNA sorting is not well understood , specific consensus sequence motifs (EXOmotifs) have been implicated (Villarroya-Beltri, Gutierrez-Vazquez et al., 2013) . miR-181a-5p has two EXOmotifs that differ from consensus sequence in one nucleotide (GGAC, UGAC), while miR-324-5p shows three motifs, one with perfect match to consensus sequence (CCCU) and two showing alteration in one nucleotide (UCCG, GGAC).
Mechanisms responsible for the reduction in KLF2 expression and signalling in PAH are currently unknown but may involve dysregulation of BMPR2 function (Eichstaedt et al., 2017) or inflammation (Kumar, Lin et al., 2005) . Inhibition of KLF2 signalling is likely to result in maladaptive responses to flow and endothelial damage (Bonnet & Provencher, 2016) . Interestingly, endothelial cells isolated from the subpleural lung microcirculation of patients with PAH at the time of transplantation or necropsy and submitted to ex vivo high shear stress exhibit delayed morphological adaptation, compared with controls (Szulcek, Happe et al., 2016) .
In summary, we show that homeostatic effects attributed to KLF2 (Bhattacharya et al., 2005) and laminar shear stress (Doddaballapur et al., 2015) can be mimicked, at least in part, by KLF2-induced exosomal miRNAs. This study provides evidence of dysregulated KLF2 signaling in PAH and highlights the potential therapeutic role of KLF2-regulated exosomal miRNAs in pulmonary hypertension and other diseases associated with endothelial damage, inflammation, proliferation and propensity for vascular cell enlargement.
MATERIALS AND METHODS
A full description of materials and methods is provided in the Online Data Supplement.
Accession numbers for miRNA microarray and RNA sequencing data will be provided upon provisional acceptance of the manuscript.
Cell culture
Human pulmonary artery endothelial cell (HPAECs, Promocell, C-12241) and human pulmonary artery smooth muscle cells (HPASMCs, Lonza, CC-2581) were cultured in endothelial cell growth medium 2 (ECGM2; PromoCell, C-22111), and smooth muscle cell growth medium 2 (SMCGM2, PromoCell, C-22062), as previously described (WojciakStothard et al., 2014a). In some experiments, the cells were incubated with human recombinant TNF-α (R&D, 210-TA-020; 10 µg/L) or exposed to hypoxia (5% CO 2 , 2%O 2 ) for 24-72 hours.
For non-contact co-culture of HPAECs and HPASMCs, Transwell dishes with 0.4 μm pore polyester membrane inserts (Scientific Laboratory Supplies, UK) were used.
Blood-derived human endothelial cell culture
Human endothelial colony forming cells (ECFCs), were derived from peripheral blood samples as previously described (Wojciak-Stothard et al., 2014a) . Clinical information is shown in Table S6 in the Online Data Supplement).
Adenoviral gene transfer
HPAECs ( 
Exosome purification and quantification
Exosomes were isolated from conditioned media of HPAECs overexpressing AdGFP or AdKLF2-GFP cultured in ECGM2 medium (PromoCell, C-22111) supplemented with 2%
exosome-depleted foetal bovine serum (Thermo Fisher, A2720801) using miRCURY™ Exosome Isolation kit (Exiqon; 300102). The particle size distribution and number in conditioned media and purified exosome fractions were studied with NanoSight LM10
Particle Size Analyzer and Particle Counter (Malvern Instruments Ltd). Exosome marker proteins were analysed by western blotting. The purity of exosome fraction was also evaluated with Exosome Array (System Biosciences, EXORAY-4).
Cell treatment with exosomes and imaging of exosome internalization
Exosomes purified from 10 ml of conditioned medium were re-suspended in 10 ml of fresh The list of KLF2-induced miRNAs was then compared with the published lists of differentially expressed miRNAs in PAH patients and PH animals (Caruso et al., 2010 , Rhodes et al., 2013 . miRNAs that were reduced in PAH but elevated by KLF2, were selected for further analysis.
Cell Transfection. 
Transfection of miRNA mimics and inhibitors was carried out with
Caspase 3/7 apoptosis assay
After an overnight incubation the cells were left in full medium or were incubated in serumand growth factor-depleted medium for 9-24 hours to induce apoptosis. Apoptosis was measured using Cell Meter TM Caspase 3/7 Activity Apoptosis Assay Kit (AAT Bioquest, ABD-22796). Fluorescence intensity was analysed in Glomax TM luminometer at Ex/Em = 490/525 nm.
NFκB luciferase reporter assay
NFκB activity was measured in luciferase reporter assay (Wojciak-Stothard et al., 2014a) in the Glomax TM luminometer.
RNA Extraction
RNA was extracted from trypsinised HPAECs or lung tissue (~10 mg) using miRCURY TM RNA Isolation Kit (Exiqon), according to manufacturer's instructions.
Real-time quantitative PCR
Input RNA (50-100 ng/µL) was reverse-transcribed using SuperScrip™ II Reverse were used to perform quantitative PCR (qPCR).
Stimulation of KLF2 expression by shear stress
HPAECs were cultured in 9-cm 2 Nunc ® Lab-Tek™ Flaskettes ® (VWR, 62407-340). The slides were detached and inserted into flow chambers in a parallel chamber flow apparatus (Wojciak-Stothard & Ridley, 2003) . Endothelial cells were subjected to laminar flow at 10 dynes/cm 2 for 24 hours. KLF2 and miRNA expression levels in cells grown under the static and flow conditions were measured by qPCR.
EdU Proliferation Assay
The EdU Cell Proliferation Assay Kit (EdU-594, EMD Millipore Corp, USA, 17-10527) was used to measure the proliferation rate in cells, according to the manufacturer's protocol.
HPASMCs or HPAECs grown in serum-reduced, growth factor-depleted medium were stimulated with 10 ng/mL PDGF (Thermo Fisher Scientific, PHG0044) or 50 ng/mL of VEGF 165 (R&D, 293-VE) 18 hours before the assay. Proliferation of ECFCs from healthy individuals and IPAH patients was evaluated in serum-reduced, growth factor-depleted media.
RNA-Sequencing
Next-generation RNA-sequencing of HPAECs transfected with miR-181 or miR-324 was performed in duplicate at the Imperial BRC Genomics Facility (Imperial College of London, UK). RNA libraries were prepared using TruSeq ® Stranded mRNA HT Sample Prep Kit (Illumina Inc., USA) according to the manufacturer's protocol. Libraries were run over 4 lanes (2 x 100 bp) on a HiSeq 2500 (Illumina Inc.) resulting in an average of 34.4 million reads per sample.
Sequence data was de-multiplexed using bcl2fastq2 Conversion Software v2.18 (Illumina Inc.) and quality analysed using FastQC. Transcripts from paired-end stranded RNA-Seq data were quantified with Salmon v0.8.2 using hg38 reference transcripts (Patro, Duggal et al., 2017) . Count data was normalised to accommodate known batch effects and library size using DESeq2 (Anders, Pyl et al., 2015 , Love, Huber et al., 2014 . Pairwise differential expression analysis was performed based on a model using the negative binomial distribution and p-values were adjusted for multiple test correction using the Benjamini-Hochberg procedure. Genes were considered differentially expressed if the adjusted p-value was greater than 0.05 and there was at least a 1.5 fold change in expression. miRNA target prediction was carried out with TargetScan Human, miRecords and Ingenuity Expert Findings. Gene enrichment was carried out using Panther v14.0 (Thomas, Campbell et al., 2003) .
Animal experiments
All studies were conducted in accordance with UK Home Office Animals (Scientific Procedures) Act 1986. All animals were randomly allocated to groups, and all personnel of small intrapulmonary arteries, as described previously (Wojciak-Stothard et al., 2014a) .
Immunostaining
Immunostaining of paraffin embedded lung sections was carried out as previously described (Wojciak-Stothard et al., 2014a) .
Western blot analysis
Primary antibodies used in western blot analysis included goat polyclonal anti-KLF2 antibody (1:1000; Novus Biologicals, NB100-1051), mouse monoclonal anti-β-actin (1:3000;
Sigma-Aldrich, A2228), Notch4 (1:1000; Santa Cruz Biotechnology, sc-393893), ETS-1
(1:1000; Santa Cruz Biotechnology, sc-55581), α-SMA (1:1000; Sigma, A5228) and rabbit were used (Pradere, Hernandez et al., 2016) .
Nuclear translocation of p65NFκB
Nuclear translocation of p65 NFκB was studied with Image J by measuring colocalisation of nuclear stain DAPI with p65NFκB stained with rabbit p65 antibody (1:1000, Santa Cruz
Biotechnology, SC-372-G) and TRITC-labelled goat anti-rabbit antibody (1:200, Jackson
ImmunoResearch Laboratories, 111-025-144) in confocal images of cells or lung sections.
The white pixel area, marking nuclear NFκB, was used to quantitate p65 NFκB translocation in cells and tissues.
RNAscope ® in situ hybridisation
Histological sections of lung tissues from treatment-naïve PAH patients at lung transplantation (n=6), and control tissues comprising uninvolved regions of lobectomy specimens from 4 patients undergoing surgery for bronchial carcinoma and 2 unused donor lungs were from the tissue archives (Abdul-Salam, Wharton et al., 2010) at Hammersmith Hospital, Imperial College London, UK. Samples were fixed in 10% formal-saline and embedded in wax, and sections were processed for immunohistochemistry as previously described (Wojciak-Stothard, Abdul-Salam et al., 2014b) . Sections from HPAH patients with c-terminal missense mutation in KLF2 gene were obtained from 3 family members, father who died aged 32 and his two daughters who underwent lung transplantation (Eichstaedt et al., 2017) . Lung sections from healthy and Sugen/hypoxia mice were also used for the analysis. 
Angiogenesis assay
ECFC angiogenesis was studied in matrigel tube formation assay (Wojciak-Stothard et al., 2014a) .
Statistics
All experiments were performed at least in triplicate. Data are presented as means±SEM. 
